Public Meetings on Section 406(b) of the FDA Modernization Act of 1997

Riepilogo

The Food and Drug Administration (FDA) is announcing the following series of meetings on section 406(b) of the FDA Modernization Act of 1997 (FDAMA) to discuss how FDA can best meet its statutory obligations under the Federal Food, Drug, and Cosmetic Act (the act). The agency intends to involve participants from consumer and scientific groups and the regulated industry in drafting FDA's developmental plan to meet the objectives of FDAMA. DATES: Comments may be submitted by September 11, 1998. For the dates of each meeting, see section III of this document.